History of urological malignancies before kidney transplantation, oncological outcome on the long term
CONCLUSIONS: Well-selected patients with histories of urological malignancies greatly benefit from kidney transplantation with infrequent and late cancer recurrence. Waiting time could be optimized in low-risk prostate cancer and RCC, but more robust data are needed.PMID:34172308 | DOI:10.1016/j.acuro.2020.10.015
Source: Actas Urologicas Espanolas - Category: Urology & Nephrology Authors: R Boissier R Hidalgo O Rodr íguez Faba A Territo J D Subiela J Huguet A S ánchez-Puy A Gallioli D Vanacore A Mercade C Martinez J Palou L Guirado A Breda Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Carcinoma | Dialysis | Kidney Transplant | Kidney Transplantation | Prostate Cancer | Study | Testicular Cancer | Transplants | Urology & Nephrology | Waiting Times